SCHEMBL903733

SCHEMBL903733

Cn1c2c(c3cc(O)ccc31)C(C)(C)Oc1cc(O)ccc1-2

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
CHEK1 O14757 1/20 0.36
ALOX5 P09917 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903731 0.79 ALDH1A1 (0.43) KDM4EALDH1A1BCHEACHEHPGD
SCHEMBL1985482 0.73 WEE1 (0.40) WEE1KDM4EALDH1A1BCHEACHE
SCHEMBL26768304 0.66 KDM4E (0.50) KDM4EALDH1A1PTGS1PTGS2ESR1
SCHEMBL30629205 0.66 KDM4E (0.50) KDM4EALDH1A1PTGS1PTGS2ESR1
SCHEMBL11808516 0.66 BCHE (0.67) WEE1KDM4EALDH1A1BCHEACHE
SCHEMBL17518127 0.65 KDM4E (0.40) KDM4EALDH1A1ESR1ESR2HPGD
SCHEMBL28580853 0.65 KDM4E (0.53) WEE1KDM4EALDH1A1ESR1ESR2
SCHEMBL6955129 0.64 CYP2C19 (0.36) WEE1KDM4EALDH1A1LMNAGAA
SCHEMBL6828099 0.63 MAPT (0.47) KDM4EALDH1A1ALOX5PTGS1PTGS2
SCHEMBL10847855 0.63 KDM4E (0.47) KDM4EALDH1A1PTGS1PTGS2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012040924-A1 FUSED TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed
WO-2012041227-A1 TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed